Skip to content
InsideEdge
Investors / filer profile

Track record

What happened ~6 months after each disclosed buy

Not enough completed buys to draw the outcome line yet.

1 of 1
buys higher ~6mo later
+23.9%
median outcome
+9.9%
S&P 500 median, same spans

Disclosed positions

Estimated from their latest filings — positions may have changed since

$45.66M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$9.9M$19.7M2025 · bought $3.9M · sold $020252026 · bought $0 · sold $19.7M2026
Total +$3.90M bought · $19.74M sold
Most bought

All filings on record

Every Form 4 transaction we track for this filer

VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$857.2K
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$2.97M
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$7.72M
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$1.73M
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$1.24M
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$466.2K
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$1.34M
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$225.1K
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$1.60M
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$1.22M
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$115.9K
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$57.8K
VRTXSell
2026-02-27 · VERTEX PHARMACEUTICALS INC / MA
$191.9K
VRTXTax
2026-02-24 · VERTEX PHARMACEUTICALS INC / MA
$2.42M
VRTXTax
2026-02-17 · VERTEX PHARMACEUTICALS INC / MA
$3.17M
VRTXGrant
2026-02-17 · VERTEX PHARMACEUTICALS INC / MA
16,326
VRTXTax
2026-02-13 · VERTEX PHARMACEUTICALS INC / MA
$6.36M
VRTXTax
2026-02-10 · VERTEX PHARMACEUTICALS INC / MA
$3.89M
VRTXGrant
2026-01-22 · VERTEX PHARMACEUTICALS INC / MA
11,885
VRTXGrant
2026-01-22 · VERTEX PHARMACEUTICALS INC / MA
26,972
VRTXBuy
2025-08-06 · VERTEX PHARMACEUTICALS INC / MA
$2.23M
+23.9%
VRTXBuy
2025-08-06 · VERTEX PHARMACEUTICALS INC / MA
$1.67M
+23.9%

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.